ArticleEndocrinology2025
Ablation of Steroidogenic Superoxide Dismutase 2 Increases Oxidative Stress and Diminishes Steroid Hormone Production.
Article in Endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Chemical-Class Submixture Screening Reveals Drivers of Endocrine Disruption in Personalized Human Blood POP Mixtures.Environmental science & technology · 2026Article
- Ablation of Steroidogenic Superoxide Dismutase 2 Increases Oxidative Stress and Diminishes Steroid Hormone Production.Endocrinology · 2025Article
- Ethnomedicinal validation ofFrontiers in nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Mitochondria are a major source of reactive oxygen species, such as superoxide anion (O2●─), contain the enzyme complexes of the electron transport chain and, in steroidogenic tissues, steroid hormone synthesizing P450 enzymes. Superoxide dismutase 2 (SOD2) is the main antioxidant enzyme localized in mitochondria for protection from oxidative insult by enzymatically converting O2●─ into H2O2, which is further degraded into H2O and O2. Although expressed at high levels in steroidogenic tissues and transcriptionally regulated by trophic hormones, SOD2's role in the regulation of steroid hormone production is not fully explored. To address its role in regulating steroidogenesis, we generated adrenal, ovary, and testis tissue specific SOD2-deficient mice. Adrenal/testis and adrenal/ovary SOD2-deficient mice exhibited a marked reduction in hormone stimulated corticosterone/testosterone and corticosterone/progesterone secretion in vivo, and hormone- or hormone + high-density lipoprotein-stimulated steroid production by steroidogenic tissues in vitro, respectively. RT-quantitative PCR measurements demonstrated dramatic reduction in mRNA levels of steroidogenic P450 enzymes and cholesterol transport protein, StAR. Small, but significant, declines in mRNA levels of certain hydroxysteroid dehydrogenases were also noted. Cellular levels of key biomarkers of oxidative stress revealed that mice with steroidogenic SOD2-deficiency exhibit high oxidative stress. Steroidogenic MLTC-1 cell lines stably overexpressing pairs of mitochondrial antioxidant enzymes, Sod2-catalase, Sod2-glutathione peroxidase-1, or Sod2-glutathione peroxidase-4, showed complete protection against oxidant-mediated suppression of steroidogenesis. These results led us to conclude that SOD2 plays an essential role in the regulation of steroidogenesis and that SOD2-deficiency-induced excessive oxidative stress adversely affects steroid production in mouse adrenal glands, ovary, and testis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.